A new potent anti-inflammatory quinazolone.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004487:Edema / Q000188:drug therapy; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010653:Phenylbutazone / Q000494:pharmacology; D011799:Quinazolines / Q000009:adverse effects / Q000494:pharmacology*; D052999:Quinazolinones; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced; D013329:Structure-Activity Relationship
D000893:Anti-Inflammatory Agents; D011799:Quinazolines; D052999:Quinazolinones; C034210:2-homopiperidino-methyl-3-(2-tolyl)-4-(3H)-6-iodoquinazolone; D010653:Phenylbutazone